Growth Hormone Therapy for Muscle Regeneration in Severely Burned Patients
Active, no longer recruiting
Phase of Trial: Phase II/III
Latest Information Update: 24 Jan 2019
At a glance
- Drugs Somatrogon (Primary)
- Indications Somatotropin deficiency
- Focus Therapeutic Use
- 17 Jan 2019 Status changed from suspended to active, no longer recruiting.
- 15 Jan 2019 Planned End Date changed from 1 Oct 2019 to 1 Oct 2020.
- 15 Jan 2019 Planned primary completion date changed from 1 Oct 2019 to 1 Oct 2020.